Short-term treatment of irbesartan and hydrochlorothiazide decreases plasma N-terminal pro-brain natriuretic peptide levels in subjects with acute exacerbations of COPD

References

• VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• FruchterOYiglaMPredictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary diseaseRespirology200813685185518811883
   PubMed Web of Science ®Google Scholar
• Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest20001175 Suppl 2398S401S10843984
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• Oswald-MammosserMWeitzenblumEQuoixEPrognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressureChest19951075119311987750305
   PubMed Web of Science ®Google Scholar
• AndreassenAKWergelandRSimonsenSGeiranOGuevaraCUelandTN-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertensionAm J Cardiol200698452552916893710
   PubMed Web of Science ®Google Scholar
• MaiselASKrishnaswamyPNowakRMRapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failureN Engl J Med2002347316116712124404
   PubMed Web of Science ®Google Scholar
• YapLBMukerjeeDTimmsPMAshrafianHCoghlanJGNatriuretic peptides, respiratory disease, and the right heartChest200412641330133615486400
   PubMed Web of Science ®Google Scholar
• LangCCCoutieWJStruthersADDhillonDPWinterJHLipworthBJElevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary diseaseClin Sci19928355295331335387
   PubMed Web of Science ®Google Scholar
• MorrisonLKHarrisonAKrishnaswamyPKazanegraRCloptonPMaiselAUtility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspneaJ Am Coll Cardiol200239220220911788208
   PubMed Web of Science ®Google Scholar
• ArjamaaONikinmaaMHypoxia regulates the natriuretic peptide systemInt J Physiol Pathophysiol Pharmacol20113319120121941610
   PubMedGoogle Scholar
• TulevskiIIGroeninkMvan der WallEEIncreased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunctionHeart2001861273011410557
   PubMed Web of Science ®Google Scholar
• BandoMIshiiYSugiyamaYKitamuraSElevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonaleRespir Med199993750751410464838
   PubMed Web of Science ®Google Scholar
• D’SouzaSPYellonDMMartinCB-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel openingAm J Physiol Heart Circ Physiol20032845H1592H160012521930
   PubMed Web of Science ®Google Scholar
• TóthMVuorinenKHVuolteenahoOHypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardiumAm J Physiol19942664 Pt 2H1572H15808184936
   PubMedGoogle Scholar
• RaupachTLüthjeLKöglerHLocal and systemic effects of angiotensin receptor blockade in an emphysema mouse modelPulm Pharmacol Ther201124221522021187155
   PubMed Web of Science ®Google Scholar
• LehmanAMattmanASinDEmphysema in an adult with galactosialidosis linked to a defect in primary elastic fiber assemblyMol Genet Metab201210619910322386972
   PubMed Web of Science ®Google Scholar
• KanatFVatansevHTekeTDiuretics, plasma brain natriuretic peptide and chronic obstructive pulmonary diseaseNeth J Med200765829630017890789
   PubMed Web of Science ®Google Scholar
• ZhangJZhaoGYuXPanXIntravenous diuretic and vasodilator therapy reduce plasma brain natriuretic peptide levels in acute exacerbation of chronic obstructive pulmonary diseaseRespirology201217471572022394412
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• AaronsonNKMullerMCohenPDTranslation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populationsJ Clin Epidemiol19985111105510689817123
   PubMed Web of Science ®Google Scholar
• DesikanRMasonHLRuppMTSkehanMHealth-related quality of life and healthcare resource utilization by COPD patients: a comparison of three instrumentsQual Life Res200211873975112482158
   PubMed Web of Science ®Google Scholar
• RumsfeldJSMagidDJPlomondonMEHistory of depression, angina, and quality of life after acute coronary syndromesAm Heart J2003145349349912660673
   PubMed Web of Science ®Google Scholar
• AdrishMNannakaVBCanoEJBajantriBDiaz-FuentesGSignificance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunctionInt J Chron Obstruct Pulmon Dis2017121183118928458528
   PubMed Web of Science ®Google Scholar
• VallabhajosyulaSHaddadTMSundaragiriPRRole of B-type natriuretic peptide in predicting in-hospital outcomes in acute exacerbation of chronic obstructive pulmonary disease with preserved left ventricular function: a 5-year retrospective analysisJ Intensive Care Med2018331163564427913775
   PubMed Web of Science ®Google Scholar
• ChiSYKimEYBanHJPlasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary diseaseLung2012190327127622246552
   PubMed Web of Science ®Google Scholar
• ShujaatAMinkinREdenEPulmonary hypertension and chronic cor pulmonale in COPDInt J Chron Obstruct Pulmon Dis20072327328218229565
   PubMedGoogle Scholar
• LuchnerAStevensTLBorgesonDDDifferential atrial and ventricular expression of myocardial BNP during evolution of heart failureAm J Physiol19982745 Pt 2H1684H16899612380
   PubMedGoogle Scholar
• HøisethADOmlandTHagveTABrekkePHSøysethVNT-proBNP independently predicts long term mortality after acute exacerbation of COPD – a prospective cohort studyRespir Res20121319723107284
   PubMed Web of Science ®Google Scholar
• PavasiniRTavazziGBiscagliaSAmino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: systematic review and meta-analysisChron Respir Dis201714211712627956645
   PubMed Web of Science ®Google Scholar
• AndreasSAnkerSDScanlonPDSomersVKNeurohumoral activation as a link to systemic manifestations of chronic lung diseaseChest200512853618362416304321
   PubMed Web of Science ®Google Scholar
• Llorens-CortesCGreenbergBHuangHCorvolPTissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysisHypertension19942455385487525476
   PubMed Web of Science ®Google Scholar
• WangRZagariyaAIbarra-SungaOAngiotensin II induces apoptosis in human and rat alveolar epithelial cellsAm J Physiol19992765 Pt 1L885L88910330045
   PubMed Web of Science ®Google Scholar
• MolteniAWardWFTs’aoCHCytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonistsCurr Pharm Des20039975176112570792
   PubMed Web of Science ®Google Scholar
• AndreasSHerrmann-LingenCRaupachTAngiotensin II blockers in obstructive pulmonary disease: a randomised controlled trialEur Respir J200627597297916446313
   PubMed Web of Science ®Google Scholar
• BrackJSindoneAFunstonRIs addition of angiotensin receptor blockade superior to increasing ACE inhibitor dose in patients with heart failure?Int J Cardiol2010139330931219027970
   PubMed Web of Science ®Google Scholar
• YipGWWangMWangTThe Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fractionHeart200894557358018208835
   PubMed Web of Science ®Google Scholar
• GuyattGHFeenyDHPatrickDLMeasuring health-related quality of lifeAnn Intern Med199311886226298452328
   PubMed Web of Science ®Google Scholar
• van GestelYRHoeksSESinDDBeta-blockers and health-related quality of life in patients with peripheral arterial disease and COPDInt J Chron Obstruct Pulmon Dis2009417718319516916
   PubMedGoogle Scholar